South San Francisco, CA October 30, 2019 Press Release — Satralizumab represents a potential new approach to treating neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating disease often misdiagnosed as multiple sclerosis (MS) — SOUTH SAN FRANCISCO, CA — October…